Connection

MICHELE YORK to Neuropsychological Tests

This is a "connection" page, showing publications MICHELE YORK has written about Neuropsychological Tests.
Connection Strength

4.150
  1. The global pandemic has permanently changed the state of practice for pre-DBS neuropsychological evaluations. Parkinsonism Relat Disord. 2021 05; 86:135-138.
    View in: PubMed
    Score: 0.575
  2. Benefit of phonemic cueing on confrontation naming in Alzheimer's disease. Clin Neuropsychol. 2020 02; 34(2):368-383.
    View in: PubMed
    Score: 0.499
  3. Performance Validity in Deep Brain Stimulation Candidates. Arch Clin Neuropsychol. 2018 Jun 01; 33(4):508-514.
    View in: PubMed
    Score: 0.469
  4. The Rey 15-item memory test and Spanish-speaking older adults. Clin Neuropsychol. 2011 Oct; 25(7):1253-65.
    View in: PubMed
    Score: 0.295
  5. Enough vs. More: Neuropsychological testing is more useful than genetic testing in the baseline evaluation of Parkinson disease. Parkinsonism Relat Disord. 2023 06; 111:105403.
    View in: PubMed
    Score: 0.165
  6. Developing a Culturally Competent Neuropsychological Battery for Diagnosis of Dementia in Arabic-Speaking Patients in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):433-445.
    View in: PubMed
    Score: 0.165
  7. Culturally Competent Approaches for Neuropsychological Assessment for Differential Diagnosis of Dementia of Korean-Speaking Patients in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):459-471.
    View in: PubMed
    Score: 0.165
  8. Developing a Culturally Competent Neuropsychological Assessment Battery for Vietnamese-speaking Patients with Suspected Dementia. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):485-500.
    View in: PubMed
    Score: 0.165
  9. Clustering and switching in phonemic fluency following pallidotomy for the treatment of Parkinson's disease. J Clin Exp Neuropsychol. 2003 Feb; 25(1):110-21.
    View in: PubMed
    Score: 0.162
  10. Development of standardized regression-based formulas to assess meaningful cognitive change in early Parkinson's disease. Arch Clin Neuropsychol. 2021 Jul 19; 36(5):734-745.
    View in: PubMed
    Score: 0.146
  11. Predictors of rate of cognitive decline in patients with amnestic mild cognitive impairment. Clin Neuropsychol. 2022 01; 36(1):138-164.
    View in: PubMed
    Score: 0.135
  12. Neuropsychological outcome following unilateral pallidotomy. Brain. 1999 Dec; 122 ( Pt 12):2209-20.
    View in: PubMed
    Score: 0.130
  13. Influence of socio-demographic characteristics on DRS-2 performance in Spanish-speaking older adults. Arch Clin Neuropsychol. 2012 Aug; 27(5):545-56.
    View in: PubMed
    Score: 0.077
  14. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol. 2012 Dec; 19(12):1525-31.
    View in: PubMed
    Score: 0.077
  15. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol. 2012 Jan; 19(1):121-7.
    View in: PubMed
    Score: 0.072
  16. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011 Jun; 17(5):321-7.
    View in: PubMed
    Score: 0.071
  17. Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis. J Clin Exp Neuropsychol. 2010 Nov; 32(9):913-22.
    View in: PubMed
    Score: 0.067
  18. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci. 2009 Dec 15; 287(1-2):159-71.
    View in: PubMed
    Score: 0.064
  19. Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. Surg Neurol. 2009 May; 71(5):551-8.
    View in: PubMed
    Score: 0.059
  20. Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2008; 20(3):357-63.
    View in: PubMed
    Score: 0.057
  21. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008 Jul; 79(7):789-95.
    View in: PubMed
    Score: 0.056
  22. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis. Acta Neurochir (Wien). 2007; 149(9):857-66; discussion 866.
    View in: PubMed
    Score: 0.055
  23. A Neuropsychological Battery for the Evaluation of Dementia Among Mandarin-Speaking Older Adults in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):446-458.
    View in: PubMed
    Score: 0.041
  24. Developing a Culturally Competent Neuropsychological Assessment Battery for Farsi-speaking Patients with Suspected Dementia. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):472-484.
    View in: PubMed
    Score: 0.041
  25. Developing Culturally Competent Foreign Language Neuropsychological Assessments: Portuguese-Speaking Brazilians Living in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):501-512.
    View in: PubMed
    Score: 0.041
  26. Seizure control and cognitive outcome after temporal lobectomy: a comparison of classic Ammon's horn sclerosis, atypical mesial temporal sclerosis, and tumoral pathologies. Epilepsia. 2003 Mar; 44(3):387-98.
    View in: PubMed
    Score: 0.041
  27. Smart-Home Concept for Remote Monitoring of Instrumental Activities of Daily Living (IADL) in Older Adults with Cognitive Impairment: A Proof of Concept and Feasibility Study. Sensors (Basel). 2022 Sep 07; 22(18).
    View in: PubMed
    Score: 0.039
  28. Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease. Parkinsonism Relat Disord. 2022 02; 95:23-27.
    View in: PubMed
    Score: 0.037
  29. Assessment of deep brain stimulation candidacy during the COVID-19 pandemic: Lessons learned and future directions for neuropsychologists. Clin Neuropsychol. 2022 01; 36(1):72-84.
    View in: PubMed
    Score: 0.036
  30. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015 Jun; 86(6):622-9.
    View in: PubMed
    Score: 0.023
  31. Does apolipoprotein E genotype modify the clinical expression of ALS? Eur J Neurol. 2011 Apr; 18(4):618-24.
    View in: PubMed
    Score: 0.017
  32. Improvement of neurological symptoms and memory and emotional status in a case of seronegative Sneddon syndrome with cyclophosphamide. Clin Neurol Neurosurg. 2010 Jul; 112(6):544-7.
    View in: PubMed
    Score: 0.017
  33. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. 2010 May 03; 11(3):303-11.
    View in: PubMed
    Score: 0.017
  34. Differences between clinical subspecialties in the outpatient evaluation and treatment of dementia in an academic medical center. Dement Geriatr Cogn Disord. 2010; 29(1):28-36.
    View in: PubMed
    Score: 0.016
  35. Ethnic disparities in the treatment of dementia in veterans. Dement Geriatr Cogn Disord. 2009; 28(2):145-52.
    View in: PubMed
    Score: 0.016
  36. Predictors of individual visual memory decline after unilateral anterior temporal lobe resection. Neurology. 2009 May 26; 72(21):1837-42.
    View in: PubMed
    Score: 0.016
  37. Changes in individual and group spatial and verbal learning characteristics after anterior temporal lobectomy. Epilepsia. 2009 Jun; 50(6):1385-95.
    View in: PubMed
    Score: 0.015
  38. Memory, emotional and vocational impairments before and after anterior temporal lobectomy for complex partial seizures. Epilepsia. 2006 Nov; 47(11):1922-30.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.